CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2021	Sep. 30, 2020
Current Assets:
Cash and cash equivalents	$ 36,060,148	$ 15,508,909
U.S. Treasury Bills	6,151,385	0
Receivables	54,922	54,922
Prepaid expenses	998,482	1,313,432
Supplies used for R&D and manufacturing	2,006,584	820,052
Total current assets	45,271,521	17,697,315
Finance lease right of use assets	12,691,921	13,811,849
Operating lease right of use assets	2,056,178	1,198,958
Property and equipment, net	13,663,562	5,843,993
Patent costs, net	275,866	313,422
Deposits	1,910,917	1,670,917
Total assets	75,869,965	40,536,454
Current Liabilities:
Accounts payable	1,675,813	2,023,067
Accrued expenses	859,216	510,515
Due to employees	265,993	448,022
Derivative instruments, current portion	437,380	213,787
Lease liabilities, current portion	698,665	1,070,123
Total current liabilities	3,937,067	4,265,514
Derivative instruments, net of current portion	0	3,551,826
Finance lease liabilities, net of current portion	13,252,364	11,753,100
Operating lease liabilities, net of current portion	2,021,308	1,114,340
Other liabilities	125,000	125,000
Total liabilities	19,335,739	20,809,780
STOCKHOLDERS' EQUITY
Common stock, $.01 par value - 600,000,000 shares authorized;43,207,183 and 38,730,150 shares issued and outstanding at September 30, 2021 and 2020, respectively	432,072	387,302
Additional paid-in capital	474,298,566	401,174,675
Accumulated deficit	(418,196,412)	(381,835,303)
Total stockholders' equity	56,534,226	19,726,674
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 75,869,965	$ 40,536,454